Microsoft Ventures has contributed to a round featuring all Livongo's existing investors, which include Merck, Wanxiang and Blue Cross Blue Shield of Massachusetts.
US-based digital health technology developer Livongo Health secured $52.5m yesterday in a funding round featuring software producer Microsoft’s corporate venturing unit, Microsoft Ventures.
Venture capital firm General Catalyst and investment firm Kinnevik co-led the round, which included Singaporean government-owned investment fund EDBI, American Investment Holdings and all Livongo’s existing investors.
Livongo is developing digital technology that will help patients manage chronic conditions more easily and efficiently. It is initially focusing on diabetes, providing a mix of information, tools and support…
